PM(NOC) Proceedings:

  • JANUMET (sitagliptin and metformin): Merck Sharp & Dohme v Pharmascience and "Company X"
  • Unidentified product containing tenofovir alafenamide hemifumarate: Gilead Sciences v JAMP Pharma

Others:

  • elranatamab: Pfizer v Amgen
  • JANUMET (sitagliptin and metformin): Merck Sharp & Dohme v Pharmascience and "Company X"
  • EYLEA (aflibercept): Bayer and Regeneron v Viatris, "Company X", and "Company Y"
  • psilocybin: Therapsil, 8 named patients and 73 healthcare practitioners v Minister of Health

For complete details about these proceedings, click here.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.